Common questions about Apiretal Codeina (FAQ)
Q: What is the main difference between Apiretal (paracetamol only) and Apiretal Codeina?
A: Apiretal Codeina is a combination medicine that contains two active ingredients: acetaminophen (paracetamol) and codeine phosphate. The official product information indicates that Apiretal, in contrast, contains only acetaminophen. Therefore, the key difference is the addition of the opioid medicine, codeine.
Q: What kind of pain is Apiretal Codeina typically used to treat?
A: Regulatory documents state that this medicine is indicated for the effective, temporary relief of acute moderate pain. It is used when the pain is not sufficiently relieved by other common pain relievers, such as paracetamol or ibuprofen, when used alone.
Q: How does the combination of paracetamol and codeine work together to relieve pain?
A: The official product information describes the different actions of the two components. Paracetamol works through a mechanism of action primarily in the central nervous system (the brain and spinal cord). Codeine is an opioid that affects pain signaling pathways to provide additional relief.
Q: Why is codeine included with paracetamol in this medication?
A: Codeine is included to utilize its opioid mechanism, providing a supplemental level of pain relief. This combination is intended for use in situations where pain cannot be effectively managed by non-opioid pain relievers such as paracetamol alone.
Q: Is Apiretal Codeina considered a narcotic or opioid pain reliever?
A: Yes, the codeine component of the medicine is classified as an opioid. Due to the presence of codeine, the combination product is typically classified as a controlled substance in many regions. This classification is due to codeine being an opioid, which carries a potential risk of misuse and dependence.
Q: How quickly should someone expect Apiretal Codeina to start working?
A: Information from consumer health services indicates that the onset of pain relief is generally expected to occur within one hour after the medicine is taken.
Q: How long does the pain relief effect of Apiretal Codeina typically last?
A: Official information regarding co-codamol combinations suggests that the pain relief effect typically lasts for approximately four to five hours. This duration aligns with the general recommendation for the dosing interval.
Q: Can Apiretal Codeina be used for headache pain?
A: Yes, regulatory indications for this type of combination medicine often include the relief of pain from headaches. Official labeling specifically mentions the potential use of the medicine for headache and migraine pain relief.
Q: What are the most commonly reported side effects of Apiretal Codeina?
A: According to official regulatory documents, the most frequently reported adverse reactions include effects on the central nervous system. These commonly involve feelings of drowsiness, lightheadedness, dizziness, sedation, and gastrointestinal effects like nausea and vomiting.
Q: Is constipation a normal or expected side effect of codeine-containing medicines?
A: Yes, constipation is a recognized and frequently reported side effect of medicines that contain codeine. This side effect is related to the action of codeine on the gastrointestinal tract.
Q: Why is drowsiness listed as a side effect for this drug?
A: Drowsiness and sedation are listed in official documents because codeine is classified as an opioid and a central nervous system (CNS) depressant. CNS depressants act on the brain and can cause reduced alertness and sleepiness.
Q: What does the term 'respiratory depression' mean in relation to Apiretal Codeina?
A: Respiratory depression refers to the serious and potentially life-threatening slowing down and shallowing of breathing. Official warnings highlight that this is a risk that can occur with the use of opioid medicines, including the codeine in this product.
Q: Can a person develop tolerance to the effects of Apiretal Codeina?
A: Official labeling indicates that both physical tolerance and psychological dependence may develop with the repeated administration of codeine-containing medicines. Tolerance refers to the body's adaptation to the medication.
Q: What are the signs of physical dependence on a codeine-containing medicine?
A: Signs of physical dependence are linked to withdrawal symptoms that may occur if the medication is discontinued after prolonged use. These symptoms can include effects such as agitation, anxiety, panic attacks, palpitations, or other physical reactions.
Q: How does Apiretal Codeina interact with alcohol?
A: Official warnings strongly caution against the simultaneous use of this medicine with alcohol due to the risks. Since both alcohol and codeine are CNS depressants, their combination can significantly increase the risks of severe sedation, respiratory depression, coma, and potentially death.
Q: Can this medicine be taken with other non-prescription painkillers like ibuprofen?
A: Official labeling states the medication is intended for pain relief when other options, such as paracetamol or ibuprofen alone, are not effective. This suggests they are alternatives rather than intended for concurrent use. Combination use with non-opioid analgesics should be discussed with a prescriber.
Q: Why is it important not to take any other medicines containing paracetamol with Apiretal Codeina?
A: The reason is clearly stated in regulatory documents: to prevent exceeding the total 24-hour maximum dose of acetaminophen (paracetamol). Exceeding this limit can result in severe and potentially fatal liver damage, as acetaminophen is toxic to the liver in high doses.
Q: Is Apiretal Codeina appropriate for use in children?
A: Official documents state that codeine is contraindicated in children younger than 12 years old. It is generally only recommended for acute moderate pain in children aged 12 years and older when other pain relievers have proven ineffective.
Q: What is the reason for the age restriction on codeine use in younger patients?
A: The official restriction for children below 12 years is based on the risk of opioid toxicity. This is due to the highly variable way some young patients metabolize codeine into its active form, morphine, which can lead to dangerously high levels in the body.
Q: What does CYP2D6 ultra-rapid metabolizer mean in the context of taking codeine?
A: Regulatory warnings describe ultra-rapid metabolizers as individuals with a specific variation in the CYP2D6 enzyme. For these individuals, codeine is converted into morphine faster than usual, significantly increasing the risk of opioid toxicity.
Q: What are the known symptoms of morphine toxicity related to codeine metabolism?
A: Regulatory warnings list key symptoms of opioid toxicity which include extreme sleepiness (somnolence), reduced levels of consciousness, and small ('pinpoint') pupils. Other serious signs include respiratory depression, nausea, and vomiting.
Q: Is Apiretal Codeina safe for a patient with a history of liver problems?
A: Official labeling states that this medicine is contraindicated in patients with severe hepatic (liver) insufficiency. For patients with existing impaired liver function or chronic alcoholism, regulatory caution is advised.
Q: Is Apiretal Codeina safe for a patient with kidney problems?
A: Caution is advised in official product information for patients who have severely impaired kidney (renal) function. Reduced doses may be necessary in these situations because the kidneys are responsible for eliminating the medicine from the body.
Q: What are the concerns about using Apiretal Codeina for people with chronic lung conditions?
A: This medicine should be used with caution in patients who have decreased respiratory reserve, such as individuals with chronic obstructive pulmonary disease (COPD) or asthma. The concern is that the codeine component can cause or worsen respiratory depression.
Q: Is there a contraindication for Apiretal Codeina use after tonsillectomy or adenoidectomy?
A: Yes, official regulatory warnings state that codeine is contraindicated in all patients younger than 18 years who undergo tonsillectomy and/or adenoidectomy. This restriction is due to the increased risk of severe breathing difficulties, especially if the procedure was for obstructive sleep apnoea.
Q: Does the codeine component of the drug pass into breast milk?
A: Yes, official documents confirm that codeine and its active metabolite, morphine, can pass into breast milk. For this reason, codeine is contraindicated for use in breastfeeding mothers due to the potential risk of serious adverse reactions and toxicity to the nursing infant.
Q: What is the distinction between addiction and physical dependence for this type of medication?
A: Official labeling notes that codeine carries risks for both physical dependence and psychological dependence (addiction). Physical dependence develops when the body adapts to the medication and withdrawal symptoms occur if it is stopped suddenly. Psychological dependence refers to the compulsive need to use the substance for its mental effects.
Q: What common medications are known to interact with the codeine component?
A: Regulatory documents list that this medicine may interact with other central nervous system (CNS) depressants. This includes drug classes like benzodiazepines, sedative-hypnotics, and certain antidepressants. Combining these substances increases the risk of excessive sedation and respiratory depression.
Q: Is it possible for Apiretal Codeina to cause blood pressure changes?
A: Official warnings advise caution in patients with pre-existing hypotension (low blood pressure). Opioid medicines, including the codeine component, have the potential to lower blood pressure, and this effect should be considered.
Q: Can Apiretal Codeina affect the results of a blood test?
A: The official labeling indicates that codeine may affect the results of certain laboratory tests. Specifically, the use of codeine may cause an increase in serum amylase levels, which should be noted when blood tests are being evaluated.
Q: Is Apiretal Codeina commonly used to suppress a cough?
A: Codeine is an opioid medicine authorized for two uses: pain relief and for treating symptoms of cough and cold. However, there are specific regulatory restrictions on its use for cough and cold symptoms, particularly in the pediatric population.
Q: Can taking this medicine cause a headache or make an existing one worse?
A: Official safety information includes warnings that the prolonged use of analgesics, including this combination medicine, may lead to the development or worsening of headaches. This condition is sometimes known as medication-overuse headache.
Q: Is it true that Apiretal Codeina is used for pain relief when other medicines like paracetamol alone haven't worked?
A: Yes, this is consistent with the official indication for the medicine. Regulatory documents state that the product is intended for pain relief only if the pain cannot be relieved by other commonly available painkillers, such as paracetamol or ibuprofen, when used alone.
Q: Is it safe to take this medicine if a person has a history of seizures?
A: Official product information advises that codeine should be used with caution in patients with convulsive disorders or a history of seizures. This caution is based on the potential effects of the medicine on the central nervous system.
Q: What is the concern about using Apiretal Codeina during pregnancy?
A: Regulatory information indicates that long-term use of this medication during pregnancy may cause dependence in the newborn, potentially leading to withdrawal signs after birth. Use during pregnancy is generally recommended only after careful professional assessment of the risks and benefits.
Q: Are there any known allergic reaction symptoms associated with Apiretal Codeina?
A: Yes, adverse reaction reports list allergic reactions, including hypersensitivity and rash. In rare cases, severe skin reactions have been reported. Given the severity of potential allergic reactions, seeking immediate medical assistance is important if symptoms appear.
Q: Why is the duration of treatment for Apiretal Codeina often limited to a few days?
A: Treatment duration is strictly limited, such as to 3 consecutive days, to minimize specific risks associated with the codeine component. The limitation is intended to reduce the potential for developing tolerance, physical dependence, and addiction.
Q: Is it safe to drive or operate machinery while taking Apiretal Codeina?
A: No, codeine may impair the mental and physical abilities required for potentially hazardous tasks. Due to the risk of impairment, official product information advises against engaging in tasks such as driving a car or operating machinery while using this medicine.
Q: Why are people with obstructive sleep apnoea often advised not to take codeine?
A: Patients with obstructive sleep apnoea are known to be at a higher risk of breathing problems with the use of codeine. Official documents warn that codeine can increase the risk of severe and life-threatening respiratory depression in this patient population.
Q: What is the legal status of Apiretal Codeina (e.g., prescription-only or over-the-counter)?
A: Regulatory classification in many regions, such as the U.S., places this product as a Schedule V controlled substance due to its codeine component. This status requires specific regulatory controls for dispensing and access.
Q: Why are patients with a history of drug or alcohol dependence monitored more closely when using this medicine?
A: Official warnings state that patients with a history of drug abuse or dependence should be monitored closely. This increased vigilance is due to the inherent risks of hazardous and harmful use of opioids, which can escalate to abuse, overdose, and potentially death.
Q: Can this medication affect a patient's emotional state, like causing anxiety or agitation?
A: Yes, the adverse reactions list in official labeling includes reported emotional changes. These effects on mood can include feelings of euphoria (an exaggerated sense of well-being) and dysphoria (a state of dissatisfaction, anxiety, or restlessness).
